News|Videos|September 24, 2026

PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP

Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.

Multi-agent AI is edging toward the pharmaceutical shop floor, and the question of where the human gate belongs in a validated GxP environment is no longer theoretical. In Part 2 of the three-part first episode of the PharmTech AI Pulse Check video series, Christopher Cole, associate editorial director, PharmTech, asks for insights from co-hosts Florin Muraru, an independent regulatory advisor; Gourav Pandey, R&D quality lead at Takeda; and Richard Jaenisch, senior director at Open Biopharm (Watch Part 1: Fixing AI Slop at the Source). The conversation opens with a recent benchmark test in which OpenAI agents reportedly built a private coordination channel days after it was shut down, and asks how pharma's segregation-of-duties playbook should respond.

Related to this article

Ask the Expert: Post-Approval Changes
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
CPHI Milan 2026: Trends in Pharma
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.